PALISADE BIO, INC. Cash and Cash Equivalents, Period Increase (Decrease)
PALISADE BIO, INC. (PALI) reported Cash and Cash Equivalents, Period Increase (Decrease) of $4.92 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-05-15
- PALISADE BIO, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was $4.92M.
- PALISADE BIO, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was -$2.18M, a 4454.08% decline year-over-year.
- PALISADE BIO, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $5.02M.
- PALISADE BIO, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$1.72M.
- PALISADE BIO, INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$672.19K.
- PALISADE BIO, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$887.83K.
- PALISADE BIO, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$8.52M, a 181.31% decline from fiscal 2016.
- PALISADE BIO, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $10.48M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|
| 2020-03-31 | $4.92M 10-Q · filed 2020-05-15 | $2.73M derived: sum of 2 quarters · filed 2020-05-15 | $7.75M derived: sum of 3 quarters · filed 2020-05-15 | $6.02M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2019-12-31 | -$2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $2.83M derived: sum of 2 quarters · filed 2020-03-27 | $1.11M derived: sum of 3 quarters · filed 2020-03-27 | -$672.19K 10-K · filed 2020-03-27 | |
| 2019-09-30 | $5.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $3.29M derived: sum of 2 quarters · filed 2019-11-14 | $1.51M 10-Q · filed 2019-11-14 | $1.56M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2019-06-30 | -$1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$3.51M 10-Q · filed 2019-08-14 | -$3.46M derived: sum of 3 quarters · filed 2020-05-15 | -$4.81M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2019-03-31 | -$1.78M 10-Q · filed 2020-05-15 | -$1.73M derived: sum of 2 quarters · filed 2020-05-15 | -$3.09M derived: sum of 3 quarters · filed 2020-05-15 | -$5.72M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $50.18K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$1.31M derived: sum of 2 quarters · filed 2020-03-27 | -$3.94M derived: sum of 3 quarters · filed 2020-03-27 | -$887.83K 10-K · filed 2020-03-27 | |
| 2018-09-30 | -$1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$3.99M derived: sum of 2 quarters · filed 2019-11-14 | -$938.01K 10-Q · filed 2019-11-14 | -$3.33M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | -$2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $417.89K 10-Q · filed 2019-08-14 | -$1.97M derived: sum of 3 quarters · filed 2019-08-14 | $650.35K derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $3.05M 10-Q · filed 2019-05-14 | $660.54K derived: sum of 2 quarters · filed 2019-05-14 | $3.28M derived: sum of 3 quarters · filed 2019-05-14 | -$1.96M derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-12-31 | -$2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $232.46K derived: sum of 2 quarters · filed 2019-03-22 | -$5.01M derived: sum of 3 quarters · filed 2019-03-22 | -$8.52M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$2.62M derived: sum of 2 quarters · filed 2018-11-14 | -$6.13M 10-Q · filed 2018-11-14 | $3.39M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | -$5.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$8.75M 10-Q · filed 2018-08-13 | $766.36K derived: sum of 3 quarters · filed 2018-08-13 | -$4.69M derived: sum of 4 quarters · filed 2018-08-13 | |
| 2017-03-31 | -$3.51M 10-Q · filed 2018-05-15 | $6.00M derived: sum of 2 quarters · filed 2018-05-15 | $551.74K derived: sum of 3 quarters · filed 2018-05-15 | $4.06M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $9.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $4.07M derived: sum of 2 quarters · filed 2018-04-02 | $7.57M derived: sum of 3 quarters · filed 2018-04-02 | $10.48M 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$5.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$1.94M derived: sum of 2 quarters · filed 2017-11-08 | $959.60K 10-Q · filed 2017-11-08 | -$7.45M derived: sum of 4 quarters · filed 2017-11-08 | |
| 2016-06-30 | $3.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $6.41M 10-Q · filed 2017-08-08 | -$2.00M derived: sum of 3 quarters · filed 2017-08-08 | $2.48M derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-03-31 | $2.90M 10-Q · filed 2017-05-10 | -$5.51M derived: sum of 2 quarters · filed 2017-05-10 | -$1.03M derived: sum of 3 quarters · filed 2017-05-10 | -$5.97M derived: sum of 4 quarters · filed 2017-05-10 | |
| 2015-12-31 | -$8.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | -$3.93M derived: sum of 2 quarters · filed 2017-03-23 | -$8.88M derived: sum of 3 quarters · filed 2017-03-23 | -$7.80M 10-K · filed 2017-03-23 | |
| 2015-09-30 | $4.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$462.67K derived: sum of 2 quarters · filed 2016-11-08 | $611.82K 10-Q · filed 2016-11-08 | $1.19M derived: sum of 4 quarters · filed 2016-11-08 | |
| 2015-06-30 | -$4.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$3.87M 10-Q · filed 2016-08-11 | -$3.30M derived: sum of 3 quarters · filed 2016-08-11 | -$6.58M derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-03-31 | $1.07M 10-Q · filed 2016-05-09 | $1.65M derived: sum of 2 quarters · filed 2016-05-09 | -$1.64M derived: sum of 3 quarters · filed 2016-05-09 | -$4.75M derived: sum of 4 quarters · filed 2016-05-09 | |
| 2014-12-31 | $573.73K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$2.71M derived: sum of 2 quarters · filed 2016-03-14 | -$5.82M derived: sum of 3 quarters · filed 2016-03-14 | -$4.33M 10-K · filed 2016-03-14 | |
| 2014-09-30 | -$3.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$6.40M derived: sum of 2 quarters · filed 2015-11-09 | -$4.90M 10-Q · filed 2015-11-09 | -$4.46M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-06-30 | -$3.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$1.61M 10-Q · filed 2015-08-10 | -$1.17M derived: sum of 3 quarters · filed 2016-03-14 | $4.07M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-03-31 | $1.50M 10-Q · filed 2015-05-08 | $1.94M derived: sum of 2 quarters · filed 2016-03-14 | $7.18M derived: sum of 3 quarters · filed 2016-03-14 | $5.68M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2013-12-31 | $444.32K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $5.68M derived: sum of 2 quarters · filed 2016-03-14 | $4.19M derived: sum of 3 quarters · filed 2016-03-14 | $9.40M 10-K · filed 2016-03-14 | |
| 2013-09-30 | $5.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $3.74M derived: sum of 2 quarters · filed 2014-11-07 | $8.96M 10-Q · filed 2014-11-07 | $6.53M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2013-06-30 | -$1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $3.72M 10-Q · filed 2014-08-08 | $1.29M derived: sum of 3 quarters · filed 2015-03-16 | $8.63M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2013-03-31 | $5.22M 10-Q · filed 2014-05-12 | $2.79M derived: sum of 2 quarters · filed 2015-03-16 | $10.12M derived: sum of 3 quarters · filed 2015-03-16 | $7.52M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2012-12-31 | -$2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $4.90M derived: sum of 2 quarters · filed 2015-03-16 | $2.30M derived: sum of 3 quarters · filed 2015-03-16 | $5.09M 10-K · filed 2015-03-16 | |
| 2012-09-30 | $7.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $4.73M derived: sum of 2 quarters · filed 2013-11-12 | $7.52M 10-Q · filed 2013-11-12 | $5.68M derived: sum of 4 quarters · filed 2014-03-10 | |
| 2012-06-30 | -$2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $187.52K 10-Q · filed 2013-08-08 | -$1.66M derived: sum of 3 quarters · filed 2014-03-10 | -$3.60M derived: sum of 4 quarters · filed 2014-03-10 | |
| 2012-03-31 | $2.79M 10-Q · filed 2013-05-10 | $948.66K derived: sum of 2 quarters · filed 2014-03-10 | -$997.71K derived: sum of 3 quarters · filed 2014-03-10 | -$3.40M derived: sum of 4 quarters · filed 2014-03-10 | |
| 2011-12-31 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | -$3.79M derived: sum of 2 quarters · filed 2014-03-10 | -$6.19M derived: sum of 3 quarters · filed 2014-03-10 | -$6.91M 10-K · filed 2014-03-10 | |
| 2011-09-30 | -$1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$4.35M derived: sum of 2 quarters · filed 2012-11-09 | -$5.07M 10-Q · filed 2012-11-09 | -$7.39M derived: sum of 4 quarters · filed 2012-11-09 | |
| 2011-06-30 | -$2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$3.12M 10-Q · filed 2012-08-09 | -$3.12M 10-Q · filed 2011-08-09 | -$5.45M derived: sum of 3 quarters · filed 2012-08-09 | -$7.88M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-03-31 | -$714.81K 10-Q · filed 2012-05-09 | -$3.04M derived: sum of 2 quarters · filed 2012-05-09 | -$5.48M derived: sum of 3 quarters · filed 2012-05-09 | ||
| 2010-12-31 | -$2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$4.76M derived: sum of 2 quarters · filed 2012-03-30 | $6.95M 10-K · filed 2012-03-30 | ||
| 2010-09-30 | -$2.44M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | $9.28M 10-Q · filed 2011-11-09 | |||
| 2010-06-30 | $11.72M 10-Q/A · filed 2011-09-23 | ||||
| 2009-12-31 | -$2.59M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |